A Semi-Supervised Generative Adversarial Network for Prediction of
  Genetic Disease Outcomes by Davi, Caio & Braga-Neto, Ulisses
A Semi-Supervised Generative Adversarial Network
for Prediction of Genetic Disease Outcomes
Caio Davi
Department of Electrical and Computer Engineering
Texas A&M University
College Station, United States
caio.davi@tamu.edu
Ulisses Braga-Neto
Department of Electrical and Computer Engineering
Texas A&M University
College Station, United States
ulisses@tamu.edu
Abstract—For most diseases, building large databases of la-
beled genetic data is an expensive and time-demanding task.
To address this, we introduce genetic Generative Adversarial
Networks (gGAN), a semi-supervised approach based on an
innovative GAN architecture to create large synthetic genetic
data sets starting with a small amount of labeled data and a
large amount of unlabeled data. Our goal is to determine the
propensity of a new individual to develop the severe form of
the illness from their genetic profile alone. The proposed model
achieved satisfactory results using real genetic data from different
datasets and populations, in which the test populations may
not have the same genetic profiles. The proposed model is self-
aware and capable of determining whether a new genetic profile
has enough compatibility with the data on which the network
was trained and is thus suitable for prediction. The code and
datasets used can be found at (suppressed in anonymous version)
https://github.com/caio-davi/gGAN
Index Terms—generative adversarial networks, genetics, semi-
supervised learning, dengue fever
I. INTRODUCTION
Creating large genetic datasets is an expensive and time-
demanding task in the case of most diseases, as it involves
patient recruitment, laboratory work, sequencing equipment,
and bioinformatics expertise. In many instances, data is clas-
sified as Protected Health Information (PHI) [1], making it
difficult to obtain and to handle. There is also a range of
intrinsic characteristics within this domain that increase the
complexity of archiving and handling this data. Firstly, it may
be difficult to obtain patients from the right population to
extract the genetic material from. Secondly, maintaining the
quality of the analysis is not a trivial process due to biological
and technical noise, which varies between laboratories and/or
between batches.
With current advancements in Machine Learning algorithms
applied to human genetics [2]–[4], large datasets are increas-
ingly needed in order to support the use and analysis of a va-
riety of data-intensive algorithms. Therefore, new mechanisms
that are capable of generating coherent synthetic genetic data
would be a remarkable advancement within this field.
However, genetic data on neglected diseases is notoriously
scarce. This is the case of Dengue disease, a viral disease
most commonly found in tropical areas of under-developed
and developing countries. Dengue is a global public health
concern with an annual global incidence of 390 million cases
[5]. There is evidence supporting that the disease progression
is genetically influenced [6]–[9], but, as mentioned previously,
genetic data on Dengue is scarce.
Recently, we employed machine learning algorithms to find
associations between profiles of single-nucleotide polymor-
phisms (SNPs) and disease severity using a small data set from
a cohort of patients in Recife, Brazil [10]. In this paper, we
propose gGAN, an innovative Generative Adversarial Network
(GAN) architecture to create large synthetic genetic data
starting with the small amount of labeled data used in the
previous study and a large amount of unlabeled data from the
human 1000 genome project. This leads to a semi-supervised
classifier that is able to predict the genetic predisposition to
severe dengue of a patient, even if their genetic profile is from
a different population than the one originally used to train the
classifier (in this case, a Brazilian population). The classifier
is self-aware in that one of the outputs of the proposed GAN
is able to discriminate whether a given test genetic profile is
sufficiently compatible with the genetic profiles in the training
population. Even though we use dengue to demonstrate our
method, it is entirely general and can be applied to other
diseases.
II. BACKGROUND
Genome-wide association studies (GWAS) are a powerful
tool for identifying genetic influences in diseases, particularly
for conditions influenced by a variety of genes and environ-
mental factors at once [11]. These techniques are historically
used for finding genetic differences in case-controlled studies
for particular diseases.
One of the biggest concerns related to genetic studies is
the size of the patient cohort used in the experiments. As
mentioned previously, obtaining a patient cohort is a hard and
expensive task. Moreover, the discrepancy between the size of
the cohort and the number of features is a frequent burden.
This occurs due to the large number of Single Nucleotide
Polymorphisms (SNPs) in the human genome, which, on
average, occur almost once in every 1,000 nucleotides. This
means there are roughly 4 to 5 million SNPs in a person’s
genome. This factor can easily lead to overfitting due to
the curse of dimensionality [12]. To overcome this, feature
selection becomes necessary.
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Fig. 1. Data preprocessing procedure. Each line in each dataset represents a genetic profile of a patient. The SNPs are selected according to an Allelic
Frequency Distance (AFD) threshold and the SVM-RFE algorithm in [10]. In this figure, AFD thresholds of 0.07, 0.10, 0.21 are depicted.
Dengue disease is a global public health concern caused
by the Dengue Virus (DENV), a positive-sense RNA virus
from the Flaviviridae family. According to the 2009 World
Health Organization (WHO) Dengue classification guideline
[13], symptomatic infection by DENV can range from a mild
disease know as Dengue Fever (DF), to a more severe disease
known as Severe Dengue (SD), which displays hemorrhagic
complications that may eventually culminate in the death of
the host individual.
There is evidence that some individuals may be genetically
predisposed to some prognostic of the Dengue disease [6],
[7]. More specifically, studies have found associations between
the genetic expression, mostly in the innate and in the adap-
tive response pathways, and the Dengue infection phenotype
[14]–[18]. Also, there are efforts to use Machine Learning
techniques to find associations between static genetic profiles
and dengue severity [10], [19].
Generative Adversarial Networks (GAN) [20] are a promis-
ing ML approach to generate synthetic data. GANs are
commonly used to generate synthetic images from a known
training set. However, there are applications of GANs in other
domains [21], including genetics [22]. There is also a report
of a semi-supervised approach to GANs [23], for classification
of the MNIST dataset [24].
III. METHODS
This section describes the steps performed to create the
model. We begin with pre-processing of our datasets, then
describe the model itself, and finally how it was trained. The
tests and results are described in the next section.
A. Data Preprocessing
We used two primary datasets from real genetic data avail-
able to the research community. The first is a dataset labeled
with the Dengue Infection phenotype in human subjects.
Patients with dengue-related symptoms were screened from
three hospitals in the city of Recife, Brazil; this population
constitutes the domain Dl. The first dataset, denoted as Xl, was
extracted from this population, and it consists of 102 patient
genotypes measured at 322 loci polymorphisms. The methods
of extraction and genotyping and cohort description for the
labeled dataset can be found in [25].
The second dataset contains unlabeled genetic data from
Phase 3 of the 1000 Genomes Project [26] (which consists of
2504 individuals genotyped for more than 84 million variants).
The 1000 Genomes Project maps genetic information from
populations around the world; we call this population Du.
The unlabeled dataset Xu consists of the same set of 322
loci in the labeled dataset, extracted from the 1000 Genomes
Collection. An important step in the manipulation of this kind
of data is that we estimated each of the allelic frequencies [27].
Different populations tend to have different frequencies due to
their diverse genomic background [28]. These differences may
affect the performance of the discriminator network, which
would try to learn from two datasets with different frequency
distributions. With this in mind, we compared these frequen-
cies between the labeled dataset and the unlabeled dataset. We
measured the frequencies for each allele of each variant in
both datasets and assume the largest difference between them
as their frequency proximity. The Allelic Frequency Distance
(AFD) between two domains is defined as
AFD = max(fi(Xl)− fi(Xu)) . (1)
In equation (1), fi is the frequency of a specific allele i within
the ni possible values for each nucleotide in population X .
After this, we established certain thresholds to sampling the
data and used them to create different INPUT configurations to
Fig. 2. Model architecture. The discriminator network is fed two datasets (labeled dataset (n=102), unlabeled dataset (n=2504)) and the synthetic genetic
profiles from the generator network. The discriminator training consists of two phases, the first using real unlabeled data and synthetic data, and the second
using labeled data.
the network. We used thresholds of 0.7, 0.1, and 0.21 resulting
in subsets of 12, 25, and 96 SNPs, as shown in Figure 1.
Those subsets were used to build the models M1, M2 and
M3, respectively.
We also used a subset of SNPs chosen in [10]. In that paper,
a Support Vector Machine was used to find the best SNPs to
discriminate Severe Dengue. As a result, 13 SNPs were found
as the most adequate ones to be used to classify the severe
form of the disease. One of those SNPs was not genotyped
in the 1000 Genome Project, so it was removed from this set,
resulting in 12 SNPs for model M4.
B. gGAN Architecture
We modified the traditional GAN architecture to work with
both labeled and unlabeled data. In the traditional GAN model,
the discriminator has only one output, which classifies the
input as real or fake (synthetic). In our case, we want to
predict the label of a test genetic profile (”Dengue Fever”
or ”Severe Dengue”) in addition to classifying between real
or fake. In order to archive this, we added a new output
to the discriminator network. This is illustrated in Figure 2.
Tables I and II give a detailed overview of the layers of the
discriminator and generator networks in the implementation
of the proposed paradigm. All layers and operators in these
tables are described in Tensorflow API notation. Notice that
all generators have inputs of the same length. The generators
are always fed with random noise, and in this case, we opted
to keep the same size for all the models. The Upsample layer
simply increases the size of the layer by duplicating it.
During training, the discriminator network weights are
updated using the labeled and unlabeled data. This update
occurs in turns (labeled and then unlabeled) for each epoch
of training. First the network Mm,disc, for m = 1, . . . , 4, is
TABLE I
ARCHITECTURE OF THE DISCRIMINATOR NETWORKS.
M1,disc M2,disc M3,disc M4,disc
input(12,1) input(25,1) input(96,1) input(12,1)
ReLu(12,24) ReLu(25,50) ReLu(96,180) ReLu(12,24)
ReLu(12,48) ReLu(25,100) ReLu(96,360) ReLu(12,48)
ReLu(12,24) ReLu(25,50) ReLu(96,180) ReLu(12,24)
Flatten Flatten Flatten Flatten
Dropout Dropout Dropout Dropout
Outputl(2, 1) Outputl(2, 1) Outputl(2, 1) Outputl(2, 1)
Outputu(2, 1) Outputu(2, 1) Outputu(2, 1) Outputu(2, 1)
TABLE II
ARCHITECTURE OF THE GENERATOR NETWORKS.
M1,gen M2,gen M3,gen M4,gen
input(100) input(100) input(100) input(100)
ReLU(24) ReLU(50) ReLU(90) ReLU(24)
UpSample(48) UpSample(100) UpSample(180) UpSample(48)
ReLU(48) ReLU(100) ReLU(180) ReLU(48)
UpSample(96) UpSample(200) UpSample(360) UpSample(96)
ReLu(12) ReLu(25) ReLu(96) ReLu(12)
Reshape(12,1) Reshape(25,1) Reshape(96,1) Reshape(12,1)
exposed to the labeled samples in Dl, and a loss L(Dl) is
calculated using the binary cross-entropy [29]:
L(Dl) = − 1
N
N∑
i=1
1∑
j=0
yij log yˆij , (2)
where N is the batch size, (yi0, yi1) is a one-hot encoding
for the training label (”Dengue Fever” or ”Severe Dengue”),
and (yˆi0, yˆi1) is the softmax output of the discriminator
corresponding to training profile xi, for i = 1, . . . , N . Next,
the weights are updated using profiles in Du using the loss
function:
L(Du,Dg) = − 1
M
M∑
i=1
1∑
j=0
yij log yˆij (3)
where M is the batch size, (yi0, yi1) is a one-hot encoding
for the training label (“fake” or “real”), and (yˆi0, yˆi1) is the
softmax output of the discriminator corresponding to training
profile xi, for i = 1, . . . ,M . The training batch is composed
by unlabeled real samples (Du) and synthetic samples (Dg)
created by the generator model.
On the other hand, the weights of the generator network are
updated using random noise as the input data set, denoted by
Dr. A synthetic sample will be produced using this random
input and then the discriminator will classify it as real or fake
data. Based on this answer, the binary cross-entropy is used
to calculate the loss:
L(Dr) = − 1
P
P∑
i=1
1∑
j=0
yij log yˆij (4)
where P is the batch size, (yi0, yi1) = (0, 1) is a one-hot
encoding for the training label (all profiles are “fake”), and
(yˆi0, yˆi1) is the softmax output of the discriminator corre-
sponding to the random genetic profile xi, for i = 1, . . . , P .
IV. RESULTS
The dataset from the labeled domain Dl was split into
training and testing following a proportion of 80% for training
and the remaining 20% for testing. This resulted in a training
dataset Xltrain containing 72 labeled genetic profiles, and
testing dataset Xltest with the remaining 20 labeled profiles.
We used the whole unlabeled dataset to train during the
unlabeled step and selected 20% as a testing dataset Xutest ,
for a total of 502 unlabeled testing profiles.
In our implementation, the batch size for training the
supervised discriminator was N = 10, selected randomly from
the labeled dataset each time. Also, 50 randomly selected
profiles from the unlabeled dataset with an additional 50
profiles created by the generator network were used to train
the unsupervised discriminator, for a batch size M = 100.
Finally, P = 100 random genetic profiles were used to train
the generator model.
We followed two testing procedures to perform accuracy
estimation. The first, denoted by T1, simply measures the ac-
curacy of each of the discriminator outputs, independently. The
second, denoted by T2, aggregates both of the discriminator
outputs. Testing procedure T1 calculates the labeled accuracy
Acc(Dl) and unlabeled accuracy Acc(Du) on the testing data
sets Xltest and Xutest , respectively. Testing procedure T2 uses
the testing dataset Xltest to simulate a deployment scenario. It
is a two-step procedure: first, it checks if the discriminator
is able to recognize the test profile as a real profile, and
calculates the accuracy Acc1(Dl) on the testing dataset. After
that, it verifies if the labeled output matches the actual data
label, producing an accuracy estimate Acc2(Dl) using only the
correctly predicted profiles in the first step. The accuracy rates
obtained in our experiments according to testing procedures T1
and T2 are displayed in Table III.
The first two columns in Table III from testing procedure
T1 show good results for the unlabeled output for all models,
TABLE III
ACCURACY RATES ACCORDING TO TESTING PROCEDURES T1 AND T2 .
Models T1 T2
Acc(Dl) Acc(Du) Acc1(Dl) Acc2(Dl)
M1(AFD <0.07) 0.6111 0.8719 0.9444 0.6470
M2(AFD <0.10) 0.6999 0.9918 1.0 0.6999
M3(AFD <0.21) 0.5263 0.9919 0.9473 0.5555
M4(SVM-RFE) 0.9375 0.9430 1.0 0.9375
meaning that gGAN has good performance when differenti-
ating between real and synthetic data. Models M2, and M3
correctly classified almost all of the test profiles in the Xutest
dataset (n=500). Model M4, using the SNPs obtained by the
SVM-RFE method, showed superior results, obtaining 94.3%
accuracy when discriminating test profiles in Xutest as real or
synthetic, and nearly 93.75% accuracy on the labeled testing
profiles in Xltest (these results are similar to the ones obtained
in [10]).
The next two columns in Table III from testing procedure
T2 show that all models built with AFD SNPs display high
accuracy on testing profiles in Xltest , which reinforces the
AFD hypothesis for selecting the best SNPs. On the other
hand, AFD ignores the relationship between the SNPs and the
dengue phenotype, as it only considers the similarity between
SNPs. This can be noticed in the results for Acc2(Dl). Model
M4 is far more accurate in this respect, which confirms
that the SNPs used by M4 have information on the Dengue
phenotype.
V. CONCLUSION
In this paper, we introduced a novel approach to train GANs,
which is capable of generating labeled genetic datasets using a
small labeled dataset and a larger unlabeled dataset, exploiting
concepts of semi-supervised learning and data augmentation
to create a new approach to deal with the limited labeled data
available to researchers.
The proposed gGAN architecture modifies the usual per-
spective on GANs: instead of a tool solely designed to generate
labeled genetic profiles, it also provides a classifier with a
level of confidence. Previous ML methods to classify diseases
based on genetic information are not aware of data coming
from new populations. With gGAN, one may see the unlabeled
output as a self-aware output. While the labeled output of the
discriminator predicts whether the individual with the corre-
sponding genetic profile is likely to develop Severe Dengue,
the unlabeled output predicts whether the genetic profile is
real or synthetic. Given a real genetic profile, if the gGAN
classifies it as not real (i.e., synthetic), we can infer that it
was most likely never seen before and thus is not appropriate
for prediction by the model.
The differences within the allelic frequencies between pop-
ulations is a challenge when one is using multiples datasets
from different populations. Indeed, even the 1000 Genome
Dataset [26] is composed of different populations and is
therefore subject to a variety of allelic frequencies itself. Due
to limitations on the size of our datasets, we opted to filter the
datasets using the AFD, but other approaches would have also
been possible if a good sample of both labeled and unlabeled
data were available for a population. Since we utilized the
labeled dataset from Recife, Brazil [25], and there is no
large unlabeled dataset for this specific population, we had to
construct our own AFD thresholds. Another possible approach
to this issue would be to use Style Transfer to somehow make
the synthetic data with frequencies between those of the two
datasets.
Nevertheless, our methods produced good results using the
SNPs selected by [10] using the same labeled dataset we are
using here. In their work, they chose the 13 most representative
SNPs to classify Severe Dengue. Indeed, we had good results
using those SNPs in the labeled phase of the training and
test. However, we also had surprisingly good results using the
unlabeled output of the discriminator network, which lead us
to believe that the discriminator was able to generalize well,
even with the allelic frequencies discrepancies.
As expected, the results of the model M4 in the tests
using Xltest were far better than the models trained using
the AFD method to select SNPs. Also, the model M2 had
a fair accuracy (almost 70%) if we think of it as a triage tool
for prognosis. Those results are even more acceptable during
disease outbreaks, when more specific tests are commonly
scarce and expensive. Another important aspect is that it can
be applied at any stage of the disease, or even before infection,
and can use a broad choice of human sample tissue, since it
is only based on genetic profiles.
The COVID-19 pandemic is a good example of a scenario
where the method described here could bring great benefits
to society. Our approach could be used to help triage patients
with a level of confidence. It could also be used to avoid
exposure of healthcare professionals who are sensitive to the
disease. The proposed method could be a powerful tool to help
public health efforts against a new outbreak.
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